Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_2
2
13%
Ph phase_3
5
31%
Ph phase_4
6
38%

Phase Distribution

0

Early Stage

2

Mid Stage

11

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
2(15.4%)
Phase 3Large-scale testing
5(38.5%)
Phase 4Post-market surveillance
6(46.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
unknown3
Not yet recruiting3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (15.4%)
Phase 35 (38.5%)
Phase 46 (46.2%)

Trials by Status

completed850%
unknown319%
withdrawn213%
not_yet_recruiting319%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT07473427Phase 3

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial

Not Yet Recruiting
NCT06994052Phase 4

Study on Booster Immunization With Varicella Vaccine at Different Intervals

Completed
NCT06987942Phase 4

Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)

Completed
NCT06891872Phase 4

Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine

Not Yet Recruiting
NCT06482216

Correlation of Protection Against Varicella in an Exploratory Study

Not Yet Recruiting
NCT06314724Phase 3

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

Completed
NCT03537508Phase 3

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Completed
NCT01190228Phase 3

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV

Completed
NCT03375502Phase 2

A Study of MG1111 in Healthy Children

Completed
NCT02026089Phase 4

Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine

Withdrawn
NCT03330171Phase 4

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine

Unknown
NCT02692066

Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine.

Withdrawn
NCT01581164

Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation

Completed
NCT00806195Phase 3

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Completed
NCT01830283Phase 4

The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination

Unknown
NCT00926419Phase 2

Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery

Unknown

All 16 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
16